Thomas J. Schall - Net Worth and Insider Trading
Thomas J. Schall Net Worth
The estimated net worth of Thomas J. Schall is at least $124 Million dollars as of 2024-11-28. Thomas J. Schall is the President and CEO of ChemoCentryx Inc and owns about 2,393,352 shares of ChemoCentryx Inc (CCXI) stock worth over $124 Million. Thomas J. Schall is also the Director of Immuneering Corp and owns about 2,900 shares of Immuneering Corp (IMRX) stock worth over $6,177. Details can be seen in Thomas J. Schall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas J. Schall has not made any transactions after 2024-03-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas J. Schall
Thomas J. Schall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas J. Schall owns 1 companies in total, including ChemoCentryx Inc (CCXI) .
Click here to see the complete history of Thomas J. Schall’s form 4 insider trades.
Insider Ownership Summary of Thomas J. Schall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CCXI | ChemoCentryx Inc | 2022-08-04 | director & 10 percent owner & President & CEO and Director |
Thomas J. Schall Latest Holdings Summary
Thomas J. Schall currently owns a total of 2 stocks. Among these stocks, Thomas J. Schall owns 2,393,352 shares of ChemoCentryx Inc (CCXI) as of August 4, 2022, with a value of $124 Million and a weighting of 100%. Thomas J. Schall also owns 2,900 shares of Immuneering Corp (IMRX) as of March 22, 2024, with a value of $6,177 and a weighting of 0%.
Latest Holdings of Thomas J. Schall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CCXI | ChemoCentryx Inc | 2022-08-04 | 2,393,352 | 51.99 | 124,430,370 |
| IMRX | Immuneering Corp | 2024-03-22 | 2,900 | 2.13 | 6,177 |
Holding Weightings of Thomas J. Schall
Thomas J. Schall Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas J. Schall has made a total of 9 transactions in ChemoCentryx Inc (CCXI) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in ChemoCentryx Inc is the sale of 130,000 shares on August 4, 2022, which brought Thomas J. Schall around $7 Million.
According to the SEC Form 4 filings, Thomas J. Schall has made a total of 1 transactions in Immuneering Corp (IMRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immuneering Corp is the acquisition of 2,900 shares on March 22, 2024, which cost Thomas J. Schall around $7,395.
Insider Trading History of Thomas J. Schall
- 1
Thomas J. Schall Trading Performance
GuruFocus tracks the stock performance after each of Thomas J. Schall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas J. Schall is -43.92%. GuruFocus also compares Thomas J. Schall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas J. Schall within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas J. Schall's insider trading performs compared to the benchmark.
Performance of Thomas J. Schall
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -32.55 |  | | | | |
| Relative Return to S&P 500(%) | -28.28 | | | | | |
Thomas J. Schall Ownership Network
Thomas J. Schall Owned Company Details
What does ChemoCentryx Inc do?
Who are the key executives at ChemoCentryx Inc?
Thomas J. Schall is the director & 10 percent owner & President & CEO and Director of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , SVP & Finance & Acctg Officer Yi Ching Yau , and 10 percent owner Vifor (international) Ltd .
ChemoCentryx Inc (CCXI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
ChemoCentryx Inc Insider Transactions
Thomas J. Schall Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas J. Schall. You might contact Thomas J. Schall via mailing address: 850 Maude Avenue Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
